EUVIMEDEUVIMED entdecken
Open Access

Cross-interference of hemolysis, icterus and lipemia

Hatice Bozkurt Yavuz, Soycan Tüner

Biochemia medica · 15.06.2026 · 36 (2) · 336-343

DOI: 10.11613/bm.2026.020708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemia medica, online erschienen am 15.06.2026. Verfasst von Hatice Bozkurt Yavuz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry, Uşak University Faculty of Medicine, Uşak, Turkey. Hauptthemen laut MEDLINE: Hemolysis, Hyperlipidemias, Jaundice. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hemolysis, icterus, and lipemia (HIL) are frequent preanalytical interferences, leading to erroneous results or sample rejection. While individual effects of these indices have been studied, their interferences on each other remain largely unexplored. This study aimed to evaluate the cross-interference of HIL parameters using endogenous patient-derived samples, thereby ensuring clinically relevant conditions, and to propose a decision algorithm for improved sample quality assessment. Materials and methods: Following the CLSI-EP07 guideline, high-concentration icterus and lipemia pools from leftover clinical samples and hemolizate pool have been prepared. These pools were serially diluted with low-index serum (HIL0) to obtain defined combinations. Indices were measured using the Abbott Alinity c system. Cross interferences were calculated as percentage bias compared to baseline values.

Results

High level hemolysis remained largely unaffected by other indices. Hemolysis in the range of 2.5–10.0 g/L caused a 20–150% false increase in lipemia and a 10–60% false decrease in icterus. Conversely, lipemia in the range of 25–100 index led to a 20–150% false increase in icterus and reduced low level of hemolysis by 10–30%. Similarly, icterus at 42.75–171 µmol/L resulted in a 15–45% false reduction in low levels of hemolysis. No concentration-dependent systematic bias was observed for lipemia and icterus, whereas hemolysis showed level-dependent effects.

Conclusions

Cross-interference among HIL indices can lead to misinterpretation if indices are assessed independently. A rule-based, threshold-dependent algorithm incorporating these interactions is proposed to enhance accuracy in sample rejection decisions. Implementation of such integrated approaches, along with manufacturer transparency, may significantly improve laboratory reliability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemolysisHyperlipidemiasJaundiceHumans

Stichwörter der Autor:innen

hemolysisicterusinterferencelipemiapreanalytical phasesample handling

Autor:innen und Institutionen

  • Department of Clinical Chemistry, Uşak University Faculty of Medicine, Uşak, Turkey.

Zitieren

APA

Bozkurt Yavuz, H., & Tüner, S. (2026). Cross-interference of hemolysis, icterus and lipemia. Biochemia medica, 36(2), 336-343. https://doi.org/10.11613/bm.2026.020708

Vancouver

Bozkurt Yavuz H, Tüner S. Cross-interference of hemolysis, icterus and lipemia. Biochemia medica. 2026;36(2):336-343. doi:10.11613/bm.2026.020708

BibTeX
@article{BozkurtYavuz2026,
  author = {Bozkurt Yavuz, Hatice and Tüner, Soycan},
  title = {Cross-interference of hemolysis, icterus and lipemia},
  journal = {Biochemia medica},
  year = {2026},
  volume = {36},
  number = {2},
  pages = {336--343},
  doi = {10.11613/bm.2026.020708}
}
Kostenlos starten →